News Release(2025)

January 21, 2025

Marketing Authorization for the Oral Spleen Tyrosine Kinase Inhibitor TAVALISSE® in South Korea

January 14, 2025

Notification of co-promotion agreement termination of Minirin Melt and Desmopressin formulations

January 7, 2025

Sub-licensing Agreement for the Oral Spleen Tyrosine Kinase Inhibitor TAVALISSE® with Tai Tien Pharmaceuticals in Taiwan